Omega-3 High Doses: Upper Limits and What EFSA, FDA and Health Canada Say
What EFSA and FDA have said about high intakes of EPA and DHA, why there is no official upper limit, what trials show about high amounts, and what we could not verify.
Content last updated . This page has not been medically reviewed.
The question
People ask "how much omega-3 is too much?" This page reports what regulators and large reviews have said about high intakes of EPA and DHA. It does not tell anyone how much to take. If you take prescription omega-3 or use large amounts of any oil, your prescriber or pharmacist should know.How the sources define the terms
EFSA, the European Food Safety Authority, describes a tolerable upper intake level as "the maximum level of total chronic daily intake of a nutrient (from all sources) judged to be unlikely to pose a risk of adverse health effects to humans." [1] It is a safety ceiling from regulators, not a goal. Labels also confuse two numbers: the weight of the oil in a capsule and the EPA plus DHA it contains. Regulator figures below are always EPA plus DHA combined. See EPA and DHA per serving vs "fish oil 1,000 mg" and omega-3 units.Hypothetical example only: a label that says "fish oil 1,000 mg" and lists 180 mg EPA and 120 mg DHA contains 300 mg of EPA plus DHA per capsule, not 1,000 mg.
What regulators and reviews said
| Body, year | Statement | Population and scope |
|---|---|---|
| EFSA, 2012 | The available data were not sufficient to set an upper intake level for EPA, DHA or DPA, alone or combined. Supplemental EPA plus DHA up to 5 g a day do not raise safety concerns. [1] | Adults (EU); the panel's opinion on EPA, DHA and DPA |
| EFSA, 2012 | Up to 5 g a day does not increase reported adverse effects such as bleeding episodes, impaired glucose regulation or impaired immune function. [1] | Adults (EU) |
| EFSA, 2012 | Observed EU intakes: average adults up to 400 to 500 mg a day of long-chain omega-3, children up to about 320 mg; highest consumers up to 2,700 mg (adults) and 1,700 mg (children). [1] | EU populations at the time |
| FDA, 2019 (letter on a blood-pressure health-claim petition) | Supplements providing no more than 5 g a day of EPA and DHA, used as the label suggests, are "safe and lawful" under the health-claim rule; above 5 g there is not enough evidence to conclude, mainly about bleeding. [2] | US; health-claim safety review, not a recommended intake |
| FDA, 2019 (describing a 1997 rule) | For conventional foods, the menhaden oil rule keeps total daily EPA plus DHA from those foods at no more than 3 g per person per day; the 1997 rule found intake over 3 g a day not generally recognized as safe, citing bleeding time, LDL cholesterol and glycemic control. [2] | US; food-additive rule, not supplements |
| FDA, 2019 | Its updated review found EPA and DHA intake up to 10 g a day appears to have no adverse effect on fasting glucose or HbA1c, and may raise LDL cholesterol by about 2 to 4 mg/dL, with inconsistent studies. [2] | US; review of studies |
The EU and US statements differ in framing: EFSA says up to 5 g a day raised no concerns for adults; FDA said 5 g a day is "safe and lawful" for health-claim purposes and found the evidence insufficient beyond 5 g. Neither says that amount is needed or recommended. Health Canada: we could not read a Health Canada statement on this topic this session, so none is quoted. The NIH Office of Dietary Supplements fact sheet was also blocked to our tools, so no figure is quoted from it.
What trials show at higher amounts
- Atrial fibrillation. A 2021 meta-analysis of 7 trials (81,210 adults, average age 65) found a hazard ratio of 1.49 (95% CI 1.04 to 2.15) in trials using more than 1 g a day and 1.12 (1.03 to 1.22) at 1 g or less, with risk rising per extra gram. [3] This is a trial finding about marine omega-3 products at stated amounts, and it was published after the 2012 EFSA statement. See fish oil and atrial fibrillation.
- Prescription product label. A prescription EPA and DHA ethyl ester label lists 4 g a day as the maximum recommended dose and notes a possible link with more frequent recurrence of symptomatic atrial fibrillation in people who already have it. [4] The hospitalization rate for atrial fibrillation or flutter was 3.1% with 4 g a day of icosapent ethyl versus 2.1% with placebo. [5]
- Bleeding. Pooled trials found no overall increase, but high-dose purified EPA showed a modest rise, tied to EPA dose. [6]
- 1 g a day. The VITAL trial (25,871 adults, 1 g a day of marine omega-3) reported no excess risk of bleeding or other serious adverse events. [7]
Evidence label: mixed. Regulators weighed bleeding, glucose and LDL; trial meta-analyses added atrial fibrillation.
Limits and uncertainty
Proper evidence not found: we found no source we could read that sets a numeric upper limit for children or for pregnancy and breastfeeding. EFSA's press release says the data were insufficient to establish an upper limit for these fatty acids. [1] Long-term safety of very high amounts, and effects of oxidized oil, are not covered by the statements above. Product quality affects what you actually get: see recalls, adulteration and label accuracy.Safety and who should ask a clinician
Ask a clinician or pharmacist before using large amounts if you take a blood thinner, have an irregular heartbeat, a bleeding disorder, diabetes, are pregnant, or plan surgery. Cod liver oil adds vitamins A and D, which can be harmful in excess. [8] See the safety overview.Frequently asked questions
Is there an official upper limit for omega-3?
EFSA said the data were not sufficient to set an upper intake level for EPA, DHA or DPA, but that supplemental EPA plus DHA up to 5 g a day raised no safety concerns for adults. [1]
What does FDA say about EPA and DHA over 5 g a day?
In a 2019 letter, FDA said there was not enough scientific evidence to draw a conclusion above 5 g a day, mainly because bleeding studies did not test higher doses. [2]
Does "up to 5 g" mean 5 g is recommended?
No. Both statements are about safety evidence, not about a recommended or needed amount.
Do high amounts of fish oil raise atrial fibrillation risk?
A meta-analysis found a larger atrial fibrillation risk in trials using more than 1 g a day than in trials at 1 g or less. [3]
What did Health Canada and NIH say?
We could not read a Health Canada statement or the NIH Office of Dietary Supplements fact sheet this session, so we quote nothing from them. Check those bodies directly.
References
- EFSA, EFSA assesses safety of long-chain omega-3 fatty acids (news story, 27 July 2012). Read 2026-10-23.
- FDA, Letter on the qualified health claim petition for EPA and DHA and reduction of blood pressure (Docket FDA-2014-Q-1146), 19 June 2019. Read 2026-10-23.
- Gencer B et al., Effect of Long-Term Marine ω-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes. Circulation 2021. Read 2026-10-23.
- FDA prescribing information for omega-3-acid ethyl esters capsules, via openFDA drug label API (label effective 2023-10-06). Read 2026-10-23.
- Bhatt DL et al., Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT). N Engl J Med 2019. Read 2026-10-23.
- Javaid M et al., Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Am Heart Assoc 2024. Read 2026-10-23.
- Manson JE et al., Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (VITAL). N Engl J Med 2019. Read 2026-10-23.
- NCCIH, Omega-3 Supplements: What You Need To Know. Read 2026-10-23.